Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy (vol 52, pg 2096, 2021)

被引：0
|
作者：
Demchuk
机构：
来源：
STROKE | 2021年 / 52卷 / 08期
关键词：
D O I：
10.1161/STR.0000000000000386
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E525 / E525
页数：1
相关论文
共 13 条
  • [1] Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage ANNEXA-4 Substudy
    Demchuk, Andrew M.
    Yue, Patrick
    Zotova, Elena
    Nakamya, Juliet
    Xu, Lizhen
    Milling, Truman J., Jr.
    Ohara, Tomoyuki
    Goldstein, Joshua N.
    Middeldorp, Saskia
    Verhamme, Peter
    Lopez-Sendon, Jose Luis
    Conley, Pamela B.
    Curnutte, John T.
    Eikelboom, John W.
    Crowther, Mark
    Connolly, Stuart J.
    STROKE, 2021, 52 (06) : 2096 - 2105
  • [2] Efficacy and Safety With Andexanet Alfa in Traumatic Intracranial Hemorrhage: An ANNEXA-4 Substudy
    Milling, T. J.
    Yue, P.
    Zotova, E.
    Nakamya, J.
    Curnutte, J. T.
    Connolly, S. J.
    Demchuk, A. M.
    ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) : S78 - S79
  • [3] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan
    Toyoda, Kazunori
    Arakawa, Shuji
    Ezura, Masayuki
    Kobayashi, Rei
    Tanaka, Yoshihide
    Hasegawa, Shu
    Yamashiro, Shigeo
    Komatsu, Yoji
    Terasawa, Yuka
    Masuno, Tomohiko
    Kobayashi, Hiroshi
    Oikawa, Suzuko
    Yasaka, Masahiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (03) : 201 - 213
  • [4] The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis
    Siegal, Deborah M.
    Forbes, Nauzer
    Eikelboom, John
    Beyer-Westendorf, Jan
    Cohen, Alexander T.
    Xu, Lizhen
    Connolly, Stuart J.
    Crowther, Mark
    CIRCULATION, 2024, 149 (16) : 1315 - 1318
  • [5] ANDEXANET ALFA VERSUS 4-FACTOR PCC FOR REVERSAL OF INTRACRANIAL HEMORRHAGE ASSOCIATED WITH FACTOR XA
    Semon, Gregory
    Straughn, Angela
    Hardman, Claire
    Steel, Barbara
    Ekeh, Akpofure
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 301 - 301
  • [6] TOTAL INTRACRANIAL VOLUME MAY BE THE BEST MEASUREMENT APPROACH FOR ASSESSING HEMOSTATIC EFFICACY OF FXA INHIBITOR REVERSAL (ANNEXA-4 TRIAL) IN MULTICOMPARTMENTAL BLEEDING
    Kasickova, L.
    Choi, H.
    Al Sultan, A.
    Yue, P.
    Curnutte, J.
    Connolly, S.
    Smith, E.
    Demchuk, A.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 6 - 6
  • [7] The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis
    Siegal, Deborah
    Beyer-Westendorf, Jan
    Yue, Patrick
    Souza, Sonia
    Nakamya, Juliet
    Connolly, Stuart J.
    Crowther, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S332 - S333
  • [8] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Ammar, Abdalla A.
    Ammar, Mahmoud A.
    Owusu, Kent A.
    Brown, Stacy C.
    Kaddouh, Firas
    Elsamadicy, Aladine A.
    Acosta, Julian N.
    Falcone, Guido J.
    NEUROCRITICAL CARE, 2021, 35 (01) : 255 - 261
  • [9] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Abdalla A. Ammar
    Mahmoud A. Ammar
    Kent A. Owusu
    Stacy C. Brown
    Firas Kaddouh
    Aladine A. Elsamadicy
    Julián N. Acosta
    Guido J. Falcone
    Neurocritical Care, 2021, 35 : 255 - 261
  • [10] Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies
    Ferreira, Luan Oliveira
    Oldemburg, Ricardo Andres Leon
    Leitao Filho, Joao Monteiro
    Cerveira, Rodrigo Arcoverde
    Vasconcelos, Victoria Winkler
    da Costa, Giovana Escribano
    Rodrigues, Roseny dos Reis
    Lopes, Dielly Catrina Favacho
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
12